LU85262A1 - Derives de la furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques contenant ces derives - Google Patents

Derives de la furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques contenant ces derives Download PDF

Info

Publication number
LU85262A1
LU85262A1 LU85262A LU85262A LU85262A1 LU 85262 A1 LU85262 A1 LU 85262A1 LU 85262 A LU85262 A LU 85262A LU 85262 A LU85262 A LU 85262A LU 85262 A1 LU85262 A1 LU 85262A1
Authority
LU
Luxembourg
Prior art keywords
furo
methyl
pyridine
compound
hydroxy
Prior art date
Application number
LU85262A
Other languages
English (en)
French (fr)
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838327815A external-priority patent/GB8327815D0/en
Application filed by Scras filed Critical Scras
Publication of LU85262A1 publication Critical patent/LU85262A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU85262A 1983-04-05 1984-03-21 Derives de la furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques contenant ces derives LU85262A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8309165 1983-04-05
GB8309165 1983-04-05
GB8327815 1983-10-18
GB838327815A GB8327815D0 (en) 1983-10-18 1983-10-18 Furo-(3 4-c)-pyridine derivatives

Publications (1)

Publication Number Publication Date
LU85262A1 true LU85262A1 (fr) 1984-10-24

Family

ID=26285725

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85262A LU85262A1 (fr) 1983-04-05 1984-03-21 Derives de la furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques contenant ces derives

Country Status (29)

Country Link
US (1) US4581363A (sv)
JP (1) JPS59193888A (sv)
KR (1) KR900005518B1 (sv)
AU (1) AU582113B2 (sv)
CA (1) CA1257269A (sv)
CH (1) CH660191A5 (sv)
DE (1) DE3412885C2 (sv)
DK (1) DK157931C (sv)
DZ (1) DZ629A1 (sv)
EG (1) EG18150A (sv)
ES (1) ES531285A0 (sv)
FI (1) FI76804C (sv)
FR (2) FR2543829B1 (sv)
GR (1) GR79577B (sv)
HK (1) HK11187A (sv)
IE (1) IE57424B1 (sv)
IL (1) IL71243A (sv)
IN (1) IN160104B (sv)
IT (1) IT1173770B (sv)
LU (1) LU85262A1 (sv)
MA (1) MA20084A1 (sv)
MX (1) MX167397B (sv)
MY (1) MY8600664A (sv)
NL (1) NL190328C (sv)
NO (1) NO161802C (sv)
NZ (1) NZ207552A (sv)
OA (1) OA07699A (sv)
PT (1) PT78361B (sv)
SE (1) SE458362B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
WO2001003682A2 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
EP1872797A3 (en) * 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
EP1278526A2 (en) 2000-03-28 2003-01-29 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AU2005259735A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7812037B2 (en) * 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
IN156817B (sv) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
CA1257269A (en) 1989-07-11
IT1173770B (it) 1987-06-24
IT8420396A0 (it) 1984-04-05
FI841273A0 (fi) 1984-03-30
DK157931C (da) 1990-08-27
SE8401841L (sv) 1984-10-06
FI76804B (fi) 1988-08-31
DK178084D0 (da) 1984-04-04
SE8401841D0 (sv) 1984-04-03
IN160104B (sv) 1987-06-27
PT78361A (en) 1984-05-01
IL71243A0 (en) 1984-06-29
CH660191A5 (fr) 1987-03-31
SE458362B (sv) 1989-03-20
NO161802C (no) 1989-09-27
DZ629A1 (fr) 2004-09-13
DK178084A (da) 1984-10-06
FR2543829B1 (fr) 1986-11-21
DE3412885A1 (de) 1984-10-11
NO841322L (no) 1984-10-08
DE3412885C2 (de) 1990-10-04
AU2640184A (en) 1984-10-11
EG18150A (en) 1992-08-30
NO161802B (no) 1989-06-19
MY8600664A (en) 1986-12-31
JPH0556353B2 (sv) 1993-08-19
JPS59193888A (ja) 1984-11-02
FI76804C (sv) 1988-12-12
US4581363A (en) 1986-04-08
PT78361B (en) 1986-05-28
IE840826L (en) 1984-10-05
NL190328B (nl) 1993-08-16
MX167397B (es) 1993-03-22
MA20084A1 (fr) 1984-12-31
OA07699A (fr) 1985-08-30
HK11187A (en) 1987-02-13
NZ207552A (en) 1986-05-09
ES8601998A1 (es) 1985-11-01
FR2543829A1 (fr) 1984-10-12
AU582113B2 (en) 1989-03-16
IE57424B1 (en) 1992-09-09
IL71243A (en) 1987-12-20
GR79577B (sv) 1984-10-30
FI841273A (fi) 1984-10-06
FR2543956B1 (fr) 1986-07-04
ES531285A0 (es) 1985-11-01
NL190328C (nl) 1994-01-17
DK157931B (da) 1990-03-05
FR2543956A1 (fr) 1984-10-12
KR900005518B1 (ko) 1990-07-30
NL8401013A (nl) 1984-11-01
KR840008651A (ko) 1984-12-17

Similar Documents

Publication Publication Date Title
LU85262A1 (fr) Derives de la furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques contenant ces derives
CH649554A5 (fr) Derives de la furo-(3,4-c)-pyridine, leur preparation et compositions pharmaceutiques les contenant.
EP0031727B1 (en) Medicinal compositions comprising as an active ingredient substituted 1,4-benzoquinones
CH653025A5 (fr) Oxazolidine-2,4-diones substituees en position 5 douees d'activite hypoglycemique.
EP0296975A1 (fr) Dérivés du diméthyl-2,2 chromannol-3, procédé d'obtention et compositions pharmaceutiques les contenant
EP0389370A1 (fr) Nouveaux stéroides 19-Nor 3-céto comportant une chaîne en 17 aminosubstituée, leur procédé de préparation et les intermédiaires de ce procédé,leur application comme médicaments et les compositions pharmaceutiques les contenant
LU79824A1 (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3,leur procede de preparation et composition pharmaceutique les contenant
US4735950A (en) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
LU85635A1 (fr) Nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine,leur preparation et compositions pharmaceutiques a base de ces composes
FR2555049A1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
NO155490B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl.
FR2495155A1 (fr) Nouveaux 8-aminoalkyl-4-alkylisopsoralenes, leur procede de preparation et composition pharmaceutique les contenant
LU85583A1 (fr) Derives de la chloro-4-furo-(3,4-c)-pyridine,leur procede de preparation et compositions therapeutiques a base de ces derives
HU197004B (en) Process for producing cardiotonic pyridinyl-carbonyl-thiazolone derivatives
EP0261004B1 (fr) Nouveaux dérivés de l'imidazole et leurs sels, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
LU86136A1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques a base de ceux-ci
HU198497B (en) Process for producing tricyclic oxazolone derivatives and cardiotonic pharmaceutical compositions comprising same as active ingredient
LU86053A1 (fr) Nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques en contenant
BE845074A (fr) Nouveaux agents antiinflammatoires imidazoles, leur preparation et compositions pharmaceutiques
JPH02503432A (ja) 血中脂肪低下性の二環式化合物のイミダゾール‐２‐イル‐誘導体及びその製造方法
JPH0455191B2 (sv)
US4803210A (en) Cardiotonic tricyclic oxazolones
SU1739851A3 (ru) Способ получени производных тиено(3 @ ,4 @ :4,5)имидазо(2,1- @ )тиазола
BE889757A (fr) Nouvelles oxazolidine -2,4- diones substituees en position 5 douees d'activite hypoglycemique
WO1986000069A1 (fr) NOUVEAUX DERIVES DE L'AMINOMETHYL-6 FURO-(3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES LES CONTENANT